Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy (Q43918953)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2002

Language	Label	Description	Also known as
English	Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy	scientific article published in February 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

autotransplantation

1 reference

based on heuristic

inferred from title

author name string

Rapoport AP

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Meisenberg B

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sarkodee-Adoo C

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Fassas A

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Frankel SR

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Mookerjee B

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Takebe N

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Fenton R

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Heyman M

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Badros A

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Kennedy A

11

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jacobs M

12

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hudes R

13

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ruehle K

14

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Smith R

15

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Kight L

16

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Chambers S

17

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

MacFadden M

18

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Cottler-Fox M

19

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Chen T

20

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Phillips G

21

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tricot G

22

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

303-312

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Autotransplantation in lymphoma: better therapy or healthier patients?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

An information-intensive approach to the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703363

21 January 2018

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiapoptosis potential of bcl-2 oncogene by dephosphorylation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of a multidrug resistance gene in human cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American M

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor-induced antibody-dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11896427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BMT.1703363

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43918953&oldid=2206331886"